Sandra Pommey

4.1k total citations · 2 hit papers
26 papers, 3.2k citations indexed

About

Sandra Pommey is a scholar working on Physiology, Immunology and Oncology. According to data from OpenAlex, Sandra Pommey has authored 26 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 13 papers in Immunology and 10 papers in Oncology. Recurrent topics in Sandra Pommey's work include Adenosine and Purinergic Signaling (15 papers), Immune Cell Function and Interaction (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Sandra Pommey is often cited by papers focused on Adenosine and Purinergic Signaling (15 papers), Immune Cell Function and Interaction (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Sandra Pommey collaborates with scholars based in Canada, Australia and Belgium. Sandra Pommey's co-authors include John Stagg, Mark J. Smyth, Bertrand Allard, Jacques Galipeau, Nicoletta Eliopoulos, Laurence Lejeune, Karen M. Dwyer, Benjamin Haibe‐Kains, Sherene Loi and Janelle Sharkey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Hepatology.

In The Last Decade

Sandra Pommey

26 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

2010 479 citations John Stagg, Janelle Sharkey et al. Proceedings of the National Academy of Sciences profile →
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

2013 387 citations Sherene Loi, Sandra Pommey et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Pommey Canada	20	1.3k	1.3k	1.2k	808	647	26	3.2k
A. Kate Sasser United States	24	334 0.3×	2.6k 2.0×	1.0k 0.8×	1.8k 2.2×	893 1.4×	54	4.5k
Diana Klein Germany	32	83 0.1×	407 0.3×	245 0.2×	1.3k 1.6×	401 0.6×	74	2.3k
Taylor H. Schreiber United States	23	198 0.1×	574 0.5×	1.0k 0.8×	475 0.6×	34 0.1×	50	1.8k
Ching Ching Leow United States	18	143 0.1×	723 0.6×	501 0.4×	887 1.1×	52 0.1×	33	1.7k
Bianca Nowlan Australia	17	57 0.0×	382 0.3×	774 0.6×	520 0.6×	362 0.6×	32	1.9k
Jens-Peter Volkmer United States	21	42 0.0×	818 0.6×	2.0k 1.6×	829 1.0×	101 0.2×	37	3.0k
Kishor K. Sivaraj Germany	14	68 0.1×	496 0.4×	199 0.2×	627 0.8×	143 0.2×	18	1.5k
Arman Jahangiri United States	28	50 0.0×	390 0.3×	226 0.2×	913 1.1×	593 0.9×	66	2.8k
Marta Serafini Italy	23	36 0.0×	476 0.4×	315 0.3×	675 0.8×	509 0.8×	67	1.8k
Saoussen Karray France	18	30 0.0×	999 0.8×	1.6k 1.3×	720 0.9×	231 0.4×	36	2.6k

Countries citing papers authored by Sandra Pommey

Since Specialization

Citations

This map shows the geographic impact of Sandra Pommey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Pommey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Pommey more than expected).

Fields of papers citing papers by Sandra Pommey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Pommey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Pommey. The network helps show where Sandra Pommey may publish in the future.

Co-authorship network of co-authors of Sandra Pommey

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Pommey. A scholar is included among the top collaborators of Sandra Pommey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Pommey. Sandra Pommey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allard, Bertrand, Célia Jacoberger-Foissac, Isabelle Cousineau, et al.. (2023). Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma. Cell Reports Medicine. 4(9). 101188–101188. 19 indexed citations

Jacoberger-Foissac, Célia, Isabelle Cousineau, Yacine Barèche, et al.. (2022). CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer. Cancer Immunology Research. 11(1). 56–71. 46 indexed citations

Barèche, Yacine, Sandra Pommey, Laurence Buisseret, et al.. (2021). High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer. Journal for ImmunoTherapy of Cancer. 9(3). e001965–e001965. 21 indexed citations

Allard, Bertrand, Isabelle Cousineau, David Allard, et al.. (2019). Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis. OncoImmunology. 8(8). 1601481–1601481. 27 indexed citations

Buisseret, Laurence, Sandra Pommey, Bertrand Allard, et al.. (2018). Abstract PD6-07: Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trial. Cancer Research. 78(4_Supplement). PD6–7. 1 indexed citations

Turcotte, Martin, David Allard, Deepak Mittal, et al.. (2017). CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy. Cancer Research. 77(20). 5652–5663. 94 indexed citations

Buisseret, Laurence, Sandra Pommey, Bertrand Allard, et al.. (2017). Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trial. Annals of Oncology. 28. i11–i11. 1 indexed citations

Buisseret, Laurence, Sandra Pommey, Bertrand Allard, et al.. (2017). Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial. Annals of Oncology. 29(4). 1056–1062. 147 indexed citations

Charlebois, Roxanne, Bertrand Allard, David Allard, et al.. (2016). PolyI:C and CpG Synergize with Anti-ErbB2 mAb for Treatment of Breast Tumors Resistant to Immune Checkpoint Inhibitors. Cancer Research. 77(2). 312–319. 26 indexed citations

10.

McRae, Jennifer L., et al.. (2016). Evaluation of CD4⁺CD25^+/−CD39⁺ T‐cell populations in peripheral blood of patients following kidney transplantation and during acute allograft rejection. Nephrology. 22(7). 505–512. 18 indexed citations

11.

Turcotte, Martin, Kathleen Spring, Sandra Pommey, et al.. (2015). CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancer Research. 75(21). 4494–4503. 207 indexed citations

12.

Charlebois, Roxanne, Guillaume Chouinard, Bertrand Allard, et al.. (2015). CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer. Clinical Cancer Research. 22(1). 158–166. 162 indexed citations

13.

Spring, Kathleen, Patrick Fournier, Liette Lapointe, et al.. (2015). The protein tyrosine phosphatase DEP-1/PTPRJ promotes breast cancer cell invasion and metastasis. Oncogene. 34(44). 5536–5547. 28 indexed citations

14.

Allard, Bertrand, Sandra Pommey, Mark J. Smyth, & John Stagg. (2013). Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs. Clinical Cancer Research. 19(20). 5626–5635. 372 indexed citations

15.

Allard, Bertrand, Martin Turcotte, Kathleen Spring, et al.. (2013). Anti‐CD73 therapy impairs tumor angiogenesis. International Journal of Cancer. 134(6). 1466–1473. 144 indexed citations

16.

Pommey, Sandra, Bo Lü, Jennifer L. McRae, et al.. (2012). Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells. Hepatology. 57(4). 1597–1606. 43 indexed citations

17.

Dwyer, Karen M., Dusan Hanidziar, Prabhakar Putheti, et al.. (2010). Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype. American Journal of Transplantation. 10(11). 2410–2420. 178 indexed citations

18.

Stagg, John, Janelle Sharkey, Sandra Pommey, et al.. (2008). Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response. Proceedings of the National Academy of Sciences. 105(42). 16254–16259. 40 indexed citations

19.

Nottle, Mark B., Luke F.S. Beebe, Sharon J. Harrison, et al.. (2007). Production of homozygous α‐1,3‐galactosyltransferase knockout pigs by breeding and somatic cell nuclear transfer. Xenotransplantation. 14(4). 339–344. 64 indexed citations

20.

Stagg, John, Sandra Pommey, Nicoletta Eliopoulos, & Jacques Galipeau. (2005). Interferon-γ-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood. 107(6). 2570–2577. 237 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact